NCT00671125 - Study of Efficacy of Ramelteon in Adults With Chronic Insomnia | Biotech Hunter

Enrollment

405

Participants

Timeline

Start Date

January 31, 2003

Primary Completion Date

September 30, 2003

Study Completion Date

September 30, 2003

Conditions

Chronic Insomnia

Interventions

DRUG

Ramelteon

Ramelteon 8 mg, tablets, orally, once nightly for up to 5 weeks.

DRUG

Ramelteon

Ramelteon 16 mg, tablets, orally, once nightly for up to 5 weeks.

DRUG

Placebo

Ramelteon placebo-matching tablets, orally, once nightly for up to 5 weeks.

Trial Locations (25)

Unknown

Birmingham

Scottsdale

Hot Springs

Anaheim

Oakland

San Diego

San Francisco

Santa Monica

Miami

Pembroke Pines

Atlanta

Chicago

Overland Park

Crestview Hills

Chevy Chase

Newton

Troy

Lincoln

Las Vegas

New York

Winston-Salem

Cincinnati

Lafayette Hill

Austin

Plano